Prescription drug markups make it difficult to determine savings
It’s a mystery.
Middlemen that manage Pennsylvania’s Medicaid prescription drug program marked up a generic leukemia drug more than $3,300 while charging the state about $2,500 less than market cost for an antiseizure medication.
